ribavirin has been researched along with Disease, Pulmonary in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozlov, VK; Skipsky, IM; Stelmakh, VV; Sukhanov, DS | 1 |
| Hodson, A; Kasliwal, M; MacMahon, E; Raj, K; Streetly, M | 1 |
| Arslan, D; Benden, C; Danziger-Isakov, LA; Goldfarb, S; Sweet, S; Wong, J | 1 |
| Borczuk, AC; Brown, M; Brown, RS; Esposito, SP; Jacobson, IM; Kumar, KS; Lobritto, SJ; Russo, MW | 1 |
| Fried, MW; Russo, MW | 1 |
| Dummer, S; McCurdy, LH; Milstone, A | 1 |
| Han, DS; Jeon, YC; Kim, TY; Park, YK; Sohn, JH; Son, BK | 1 |
| Maleev, VV; Pacechnikov, VD; Sannikova, IV | 1 |
| Chen, CH; Chiang, BL; Kao, CL; Lee, JH; Lin, YT; Wang, LC; Yang, YH | 1 |
| Giffin, FJ; Greenough, A; Yüksel, B | 1 |
| Levy, H; Simpson, SQ | 1 |
| Carre, P; Didier, A; Henry, S; Icart, J; Leophonte, P; Murris-Espin, M | 1 |
| Greenberg, K; Mostow, SR; Prochoda, K | 1 |
| Basgoz, N; Flieder, DB; Ginns, LC; Kradin, R; Krinzman, S; Shepard, JA; Wain, JC; Wright, CD | 1 |
| Bailey, KW; Barnard, DL; Huffman, JH; Kim, CU; Morrison, A; Sidwell, RW; Syndergaard, T; Wong, MH | 1 |
| Faris, M; O'Riordan, T | 1 |
| Baum, KF; Behrman, RE; Bell, LJ; Chapman, LE; Christenson, JC; Ellis, BA; Hawk, J; Holman, RC; Jolson, HM; Khan, AS; Koster, FT; Ksiazek, TG; Mertz, GJ; Pavia, AT; Peters, CJ; Rollin, PE; Rubin, PJ; Simpson, GL; Sotir, M | 1 |
| Besancenot, JF; Bielefeld, P; Champigneulle, B; de Boulard, A; Gabreau, T; Hillon, P; Lévêque, L; Makki, H; Sgro, C | 1 |
| Lombraña, JL; Pérez-Alvarez, R; Pérez-López, R; Rodrigo, L; Rodríguez, M | 1 |
3 review(s) available for ribavirin and Disease, Pulmonary
| Article | Year |
|---|---|
Side effects of therapy for chronic hepatitis C.
Topics: Antiviral Agents; Drug Therapy, Combination; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lung Diseases; Mental Disorders; Nervous System Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thyroid Diseases | 2003 |
Hantavirus pulmonary syndrome.
Topics: Bunyaviridae Infections; Combined Modality Therapy; Disease Outbreaks; Hemodynamics; Humans; Lung Diseases; Orthohantavirus; Oxygen Inhalation Therapy; Prognosis; Ribavirin; Risk Factors; Southwestern United States; Syndrome | 1994 |
Inhaled antimicrobial therapy.
Topics: Administration, Inhalation; Aerosols; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiviral Agents; Bronchitis; Colony Count, Microbial; Cystic Fibrosis; Humans; Lung Diseases; Pentamidine; Pneumonia, Pneumocystis; Respiration, Artificial; Ribavirin; Sputum; Tobramycin; Tracheitis | 1999 |
4 trial(s) available for ribavirin and Disease, Pulmonary
| Article | Year |
|---|---|
Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization.
Topics: Antiviral Agents; Asthma; Bronchiolitis, Viral; Child; Child, Preschool; Chronic Disease; Cohort Studies; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Hypersensitivity; Infant; Lung Diseases; Male; Respiratory Syncytial Virus Infections; Ribavirin; Risk; Risk Factors; Taiwan; Time | 2008 |
Antiviral therapy in neonatal chronic lung disease.
Topics: Administration, Inhalation; Antiviral Agents; Chronic Disease; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature, Diseases; Lung; Lung Diseases; Male; Respiration; Respiratory Function Tests; Ribavirin | 1995 |
Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome.
Topics: Antiviral Agents; Blood Gas Analysis; Electrolytes; Female; Hantavirus Infections; Humans; Infusions, Intravenous; Kidney Function Tests; Liver Function Tests; Lung Diseases; Male; Orthohantavirus; Platelet Count; Prothrombin Time; Regression Analysis; Ribavirin; Time Factors | 2002 |
Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine.
Topics: Adult; Amantadine; Antiviral Agents; Drug Synergism; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lung Diseases; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Ribavirin; Sarcoidosis | 2002 |
12 other study(ies) available for ribavirin and Disease, Pulmonary
| Article | Year |
|---|---|
[Pulmonary vasculitis as a clinical mask of HCV infection: efficiency of interferon-free antiviral therapy].
Topics: Acridines; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Leukocytes, Mononuclear; Lung; Lung Diseases; Middle Aged; Polymerase Chain Reaction; Ribavirin; RNA, Viral; Treatment Outcome; Vasculitis | 2014 |
A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Disease Outbreaks; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Infections; Lung Diseases; Male; Middle Aged; Multiple Organ Failure; Parainfluenza Virus 3, Human; Respirovirus Infections; Ribavirin; Sepsis; Survival Rate; Transplantation, Autologous; Transplantation, Homologous | 2011 |
RSV prevention and treatment in pediatric lung transplant patients: a survey of current practices among the International Pediatric Lung Transplant Collaborative.
Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child; Child, Preschool; Humans; Infant; International Cooperation; Lung Diseases; Lung Transplantation; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2012 |
Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.
Topics: Antiviral Agents; Female; Hepatitis C; Humans; Interferons; Lung Diseases; Male; Middle Aged; Outcome Assessment, Health Care; Retrospective Studies; Ribavirin | 2002 |
Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.
Topics: Administration, Inhalation; Adult; Aged; Antiviral Agents; Bronchoalveolar Lavage; Combined Modality Therapy; Female; Forced Expiratory Volume; Graft Rejection; Humans; Immunosuppressive Agents; Lung Diseases; Lung Transplantation; Male; Middle Aged; Paramyxoviridae Infections; Polymerase Chain Reaction; Postoperative Complications; Prevalence; Retrospective Studies; Ribavirin; Seasons; Tennessee; Treatment Outcome | 2003 |
[Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis C].
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lung Diseases; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2007 |
[Respiratory lesions in Congo-Crimean hemorrhagic fever].
Topics: Acute Disease; Adult; Antiviral Agents; Blood Transfusion; Cytokines; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, Crimean; Humans; Immunoglobulin G; Lung Diseases; Male; Respiratory Tract Infections; Ribavirin | 2007 |
Continuous aerosolised tribavirin for respiratory syncytial virus infection in lung transplant recipients.
Topics: Aerosols; Humans; Lung Diseases; Lung Transplantation; Postoperative Complications; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin | 1993 |
Hantavirus-associated acute respiratory failure.
Topics: Adult; Bunyaviridae Infections; Female; Humans; Lung Diseases; Orthohantavirus; Respiratory Insufficiency; Ribavirin; Survivors | 1993 |
Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants.
Topics: Adult; Antiviral Agents; Female; Heart Transplantation; Humans; Kidney Transplantation; Lung Diseases; Lung Transplantation; Male; Middle Aged; Organ Transplantation; Radiography; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Treatment Outcome | 1998 |
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Topics: Acetamides; Administration, Intranasal; Administration, Oral; Amines; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Dogs; Enzyme Inhibitors; Female; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Lung Diseases; Mice; Mice, Inbred BALB C; Molecular Structure; Neuraminidase; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Zanamivir | 1998 |
[Sarcoidosis during the treatment of hepatitis C by interferon-alpha and ribavirin: 2 cases].
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Lung Diseases; Male; Middle Aged; Ribavirin; Sarcoidosis; Time Factors | 2001 |